Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to search for business combination targets in the pharmaceutical industry. The firm is neither engaged in any operations nor generated any revenues.
DMIIU stock price ended at $10.06 on 木曜日, after dropping 0.49%
On the latest trading day Feb 05, 2026, the stock price of DMIIU fell by 0.49%, dropping from $10.13 to $10.06. During the session, the stock saw a volatility of 0.70%, with prices oscillating between a daily low of $10.06 and a high of $10.13. On the latest trading day, the trading volume for DMIIU decreased by 970 shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 719 shares were traded, with a market value of approximately $659.7M.